Literature DB >> 11168045

Antibiotic susceptibility and genotypic characterization of Haemophilus influenzae strains isolated from nasopharyngeal specimens from children in day-care centers in eastern France.

D Talon1, J Leroy, M J Dupont, X Bertrand, F Mermet, M Thouverez, J M Estavoyer.   

Abstract

OBJECTIVE: To determine the overall carriage rate for Haemophilus influenzae in young children in day-care centers, the frequency of resistance to various classes of antibiotic, and the clonal relationship between isolates of the various resistant phenotypes.
METHODS: Nasopharyngeal (NP) specimens were obtained and cultured on chocolate agar with bacitracin. Antibiotic susceptibility testing and serotyping were performed for all isolates. The genetic polymorphism of ampicillin-susceptible and beta-lactamase-producing isolates was studied by pulsed-field gel electrophoresis using SmaI.
RESULTS: Of the 596 NP secretion cultures, 152 (25.5%) were positive for H. influenzae. Sixty-four (42.1%) isolates produced beta-lactamase and two (1.3%) were ampicillin resistant but did not produce beta-lactamase. We were unable to serotype 150 isolates; one isolate belonged to capsular serotype e and one to serotype f. Forty-six major DNA patterns were identified among 76 randomized isolates. beta-lactamase producing isolates more frequently showed EP than ampicillin-susceptible isolates P < 10(-4). The frequency of isolates with EP was significantly lower in day-care centers attended by less than 20 children than in those attended by more than 20 children (P = 0.020).
CONCLUSIONS: Resistance due to beta-lactamase production has disseminated in some day-care centers, mostly by person-to-person spread but also via the possible conjugal transfer of large plasmids between strains. The size of day-care centers may affect the risk of transmission.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11168045     DOI: 10.1046/j.1469-0691.2000.00151.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  Nasopharyngeal versus oropharyngeal sampling for isolation of potential respiratory pathogens in adults.

Authors:  David Lieberman; Elena Shleyfer; Hana Castel; Andrei Terry; Ilana Harman-Boehm; Jorge Delgado; Nechama Peled; Devora Lieberman
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

2.  Prevalence and serotype distribution of encapsulated Haemophilus influenzae isolates from patients with lower respiratory tract infections in Poland.

Authors:  Anna Skoczynska; Magdalena Lewandowska; Anna Klarowicz; Waleria Hryniewicz
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

3.  Invasive type e Haemophilus influenzae disease in Italy.

Authors:  Marina Cerquetti; Marta Luisa Ciofi degli Atti; Rita Cardines; Stefania Salmaso; Giovanna Renna; Paola Mastrantonio
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

4.  Relative importance of nasopharyngeal versus oropharyngeal sampling for isolation of Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals varies with age.

Authors:  David Greenberg; Arnon Broides; Irena Blancovich; Nechama Peled; Noga Givon-Lavi; Ron Dagan
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

5.  Possible high rate of transmission of nontypeable Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains, between children and their parents.

Authors:  Hiroshi Watanabe; Kazuhiko Hoshino; Rinya Sugita; Norichika Asoh; Kiwao Watanabe; Kazunori Oishi; Tsuyoshi Nagatake
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

6.  Epidemiology of respiratory pathogen carriage in the homeless population within two shelters in Marseille, France, 2015-2017: cross sectional 1-day surveys.

Authors:  T D A Ly; S Edouard; S Badiaga; H Tissot-Dupont; V T Hoang; V Pommier de Santi; P Brouqui; D Raoult; P Gautret
Journal:  Clin Microbiol Infect       Date:  2018-05-17       Impact factor: 8.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.